Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ
- PMID: 22348735
- PMCID: PMC3311562
- DOI: 10.1186/1471-2466-12-6
Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ
Abstract
Background: The aim of our study was to investigate the predictive value of the biomarkers interleukin 6 (IL-6), interleukin 10 (IL-10) and lipopolysaccharide-binding protein (LBP) compared with clinical CRB and CRB-65 severity scores in patients with community-acquired pneumonia (CAP).
Methods: Samples and data were obtained from patients enrolled into the German CAPNETZ study group. Samples (blood, sputum and urine) were collected within 24 h of first presentation and inclusion in the CAPNETZ study, and CRB and CRB-65 scores were determined for all patients at the time of enrollment. The combined end point representative of a severe course of CAP was defined as mechanical ventilation, intensive care unit treatment and/or death within 30 days. Overall, a total of 1,000 patients were enrolled in the study. A severe course of CAP was observed in 105 (10.5%) patients.
Results: The highest IL-6, IL-10 and LBP concentrations were found in patients with CRB-65 scores of 3-4 or CRB scores of 2-3. IL-6 and LBP levels on enrollment in the study were significantly higher for patients with a severe course of CAP than for those who did not have severe CAP. In receiver operating characteristic analyses, the area under the curve values for of IL-6 (0.689), IL-10 (0.665) and LPB (0.624) in a severe course of CAP were lower than that of CRB-65 (0.764) and similar to that of CRB (0.69). The accuracy of both CRB and CRB-65 was increased significantly by including IL-6 measurements. In addition, higher cytokine concentrations were found in patients with typical bacterial infections compared with patients with atypical or viral infections and those with infection of unknown etiology. LBP showed the highest discriminatory power with respect to the etiology of infection.
Conclusions: IL-6, IL-10 and LBP concentrations were increased in patients with a CRB-65 score of 3-4 and a severe course of CAP. The concentrations of IL-6 and IL-10 reflected the severity of disease in patients with CAP. The predictive power of IL-6, IL-10 and LBP for a severe course of pneumonia was lower than that of CRB-65. Typical bacterial pathogens induced the highest LBP, IL-6 and IL-10 concentrations.
© 2012 Zobel et al; licensee BioMed Central Ltd.
Figures




Similar articles
-
Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ.Intensive Care Med. 2007 Dec;33(12):2069-78. doi: 10.1007/s00134-007-0895-5. Epub 2007 Oct 16. Intensive Care Med. 2007. PMID: 17938883
-
Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ.Respir Res. 2009 Jul 12;10(1):65. doi: 10.1186/1465-9921-10-65. Respir Res. 2009. PMID: 19594893 Free PMC article.
-
Assessment of oxygenation and comorbidities improves outcome prediction in patients with community-acquired pneumonia with a low CRB-65 score.J Intern Med. 2015 Aug;278(2):193-202. doi: 10.1111/joim.12349. Epub 2015 Feb 13. J Intern Med. 2015. PMID: 25597400
-
[Biomarkers in community acquired pneumonia - what did we learn from the CAPNETZ study?].Pneumologie. 2011 Feb;65(2):110-3. doi: 10.1055/s-0030-1255935. Epub 2010 Nov 29. Pneumologie. 2011. PMID: 21117019 Review. German.
-
Unmet needs in pneumonia research: a comprehensive approach by the CAPNETZ study group.Respir Res. 2022 Sep 10;23(1):239. doi: 10.1186/s12931-022-02117-3. Respir Res. 2022. PMID: 36088316 Free PMC article. Review.
Cited by
-
Research progress of biomarkers in evaluating the severity and prognostic value of severe pneumonia in children.Front Pediatr. 2024 Oct 1;12:1417644. doi: 10.3389/fped.2024.1417644. eCollection 2024. Front Pediatr. 2024. PMID: 39411281 Free PMC article. Review.
-
Associations of three well-characterized polymorphisms in the IL-6 and IL-10 genes with pneumonia: a meta-analysis.Sci Rep. 2015 Feb 24;5:8559. doi: 10.1038/srep08559. Sci Rep. 2015. PMID: 25708204 Free PMC article.
-
Biomarkers in Pneumonia-Beyond Procalcitonin.Int J Mol Sci. 2019 Apr 24;20(8):2004. doi: 10.3390/ijms20082004. Int J Mol Sci. 2019. PMID: 31022834 Free PMC article. Review.
-
Major advances in managing community-acquired pneumonia.F1000Prime Rep. 2013 Oct 1;5:43. doi: 10.12703/P5-43. F1000Prime Rep. 2013. PMID: 24167724 Free PMC article. Review.
-
Novel protein biomarkers for pneumonia and acute exacerbations in COPD: a pilot study.Front Med (Lausanne). 2023 Jun 5;10:1180746. doi: 10.3389/fmed.2023.1180746. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37342494 Free PMC article.
References
-
- Welte T, Suttorp N, Marre R. CAPNETZ-community-acquired pneumonia competence network. Infection. 2004;32:234–238. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous